Overview

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Status:
RECRUITING

Trial end date:
2026-03-31

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer.

Phase:

PHASE2

Details

Lead Sponsor:

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Treatments:

Bevacizumab
Capecitabine
Oxaliplatin